Shigella infection
- Overview
- Theory
- Diagnosis
- Management
- Follow up
- Resources
Treatment algorithm
Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups: see disclaimer
suspected or confirmed shigellosis
oral rehydration solution
In Shigella dysentery, oral rehydration therapy (using approved oral rehydration solution [ORS]) is indicated in mild to moderate volume depletion. Following rehydration, maintenance therapy with ORS to ensure hydration status is recommended.[13]World Health Organization. Guidelines for the control of shigellosis, including epidemics due to Shigella dysenteriae type 1. 2005 [internet publication]. http://apps.who.int/iris/bitstream/10665/43252/1/924159330X.pdf [22]Shane AL, Mody RK, Crump JA, et al. 2017 Infectious Diseases Society of America clinical practice guidelines for the diagnosis and management of infectious diarrhea. Clin Infect Dis. 2017 Nov 29;65(12):e45-80. https://academic.oup.com/cid/article/65/12/e45/4557073 http://www.ncbi.nlm.nih.gov/pubmed/29053792?tool=bestpractice.com
Oral rehydration therapy using an approved ORS is safer than use of other beverages, which may be too concentrated and contain inappropriate carbohydrate and electrolyte concentrations. Homemade preparations may be equally problematic because errors may occur.
The World Health Organization recommends low-osmolarity ORS formula for diarrhea in all age groups.[31]UNICEF/WHO. Diarrhoea: why children are still dying and what can be done. 2009 [internet publication]. https://www.who.int/publications/i/item/9789241598415
early nutritional support + health education + infection control measures
Treatment recommended for ALL patients in selected patient group
Early nutritional support has been found to improve outcomes, especially in the context of malnutrition. Continued feeding promotes recovery. Frequent small meals with familiar foods, rich in energy and protein, should be provided. Breastfed infants and children should continue to be breastfed as often and for as long as they want.[13]World Health Organization. Guidelines for the control of shigellosis, including epidemics due to Shigella dysenteriae type 1. 2005 [internet publication]. http://apps.who.int/iris/bitstream/10665/43252/1/924159330X.pdf
The addition of green bananas to meals has been shown to reduce the duration of symptoms of shigellosis in children over 6 months of age.[32]Rabbani GH, Ahmed S, Hossain I, et al. Green banana reduces clinical severity of childhood shigellosis: a double-blind, randomized, controlled clinical trial. Pediatr Infect Dis J. 2009 May;28(5):420-5.
http://www.ncbi.nlm.nih.gov/pubmed/19319017?tool=bestpractice.com
In low- and middle-income countries, a 10- to 14-day course of zinc supplementation is recommended by the World Health Organization in children <6 years of age with acute diarrhea.[13]World Health Organization. Guidelines for the control of shigellosis, including epidemics due to Shigella dysenteriae type 1. 2005 [internet publication].
http://apps.who.int/iris/bitstream/10665/43252/1/924159330X.pdf
[ ]
Is there randomized controlled trial evidence to support the use of oral zinc to treat acute diarrhea in children?/cca.html?targetUrl=https://cochranelibrary.com/cca/doi/10.1002/cca.1546/fullShow me the answer Vitamin A is also recommended.[31]UNICEF/WHO. Diarrhoea: why children are still dying and what can be done. 2009 [internet publication].
https://www.who.int/publications/i/item/9789241598415
Information regarding personal hygiene, food, and drinking water should be provided to all patients. Outpatients should be also clearly instructed how to disinfect clothes, personal items, and their immediate environment.[13]World Health Organization. Guidelines for the control of shigellosis, including epidemics due to Shigella dysenteriae type 1. 2005 [internet publication]. http://apps.who.int/iris/bitstream/10665/43252/1/924159330X.pdf Sexual activities should be avoided while symptomatic and for up to 7 days after symptoms have stopped. Organisms in stool may continue to shed for up to 6 weeks, so fecal-oral contact during sex should be avoided for this period of time.[22]Shane AL, Mody RK, Crump JA, et al. 2017 Infectious Diseases Society of America clinical practice guidelines for the diagnosis and management of infectious diarrhea. Clin Infect Dis. 2017 Nov 29;65(12):e45-80. https://academic.oup.com/cid/article/65/12/e45/4557073 http://www.ncbi.nlm.nih.gov/pubmed/29053792?tool=bestpractice.com [33]European Centre for Disease Prevention and Control. Rapid risk assessment: increase in extensively-drug resistant Shigella sonnei infections in men who have sex with men in the EU/EEA and the UK. Feb 2022 [internet publication]. https://www.ecdc.europa.eu/en/publications-data/rapid-risk-assessment-increase-extensively-drug-resistant-shigella-sonnei
antibiotic therapy
Treatment recommended for SOME patients in selected patient group
Antibiotic therapy is reserved for where it is clinically indicated or when public health officials advise treatment in an outbreak setting or to reduce the likelihood of transmission in certain settings or situations.[35]Centers for Disease Control and Prevention. Emergency preparedness and response: increase in extensively drug-resistant shigellosis in the United States. Feb 2023 [internet publication]. https://emergency.cdc.gov/han/2023/han00486.asp Clinical indications for empirical antibiotics include all cases of fever with bloody diarrhea, bacillary dysentery, and abdominal cramping.[22]Shane AL, Mody RK, Crump JA, et al. 2017 Infectious Diseases Society of America clinical practice guidelines for the diagnosis and management of infectious diarrhea. Clin Infect Dis. 2017 Nov 29;65(12):e45-80. https://academic.oup.com/cid/article/65/12/e45/4557073 http://www.ncbi.nlm.nih.gov/pubmed/29053792?tool=bestpractice.com Antibiotics are also recommended for infants ages <3 months with suspicion of Shigella infection and people with body temperatures ≥38.5°C and/or signs of sepsis who have recently traveled internationally.[22]Shane AL, Mody RK, Crump JA, et al. 2017 Infectious Diseases Society of America clinical practice guidelines for the diagnosis and management of infectious diarrhea. Clin Infect Dis. 2017 Nov 29;65(12):e45-80. https://academic.oup.com/cid/article/65/12/e45/4557073 http://www.ncbi.nlm.nih.gov/pubmed/29053792?tool=bestpractice.com Antibiotics may be considered in people who are immunocompromised and have severe illness and bloody diarrhea.[22]Shane AL, Mody RK, Crump JA, et al. 2017 Infectious Diseases Society of America clinical practice guidelines for the diagnosis and management of infectious diarrhea. Clin Infect Dis. 2017 Nov 29;65(12):e45-80. https://academic.oup.com/cid/article/65/12/e45/4557073 http://www.ncbi.nlm.nih.gov/pubmed/29053792?tool=bestpractice.com
First-line options are azithromycin, ciprofloxacin, or ceftriaxone.[1]Center for Disease Control and Prevention. CDC Yellow Book 2024: health information for international travel. Section 5: travel-associated infections & diseases - shigellosis. Jun 2023 [internet publication]. https://wwwnc.cdc.gov/travel/yellowbook/2024/infections-diseases/shigellosis [22]Shane AL, Mody RK, Crump JA, et al. 2017 Infectious Diseases Society of America clinical practice guidelines for the diagnosis and management of infectious diarrhea. Clin Infect Dis. 2017 Nov 29;65(12):e45-80. https://academic.oup.com/cid/article/65/12/e45/4557073 http://www.ncbi.nlm.nih.gov/pubmed/29053792?tool=bestpractice.com The choice of drug is dependent on local sensitivities. If available, antimicrobial susceptibility testing should be carried out before treating with antibiotics.[1]Center for Disease Control and Prevention. CDC Yellow Book 2024: health information for international travel. Section 5: travel-associated infections & diseases - shigellosis. Jun 2023 [internet publication]. https://wwwnc.cdc.gov/travel/yellowbook/2024/infections-diseases/shigellosis The rapid emergence of fluoroquinolone resistance is a concern, particularly in India and China.[13]World Health Organization. Guidelines for the control of shigellosis, including epidemics due to Shigella dysenteriae type 1. 2005 [internet publication]. http://apps.who.int/iris/bitstream/10665/43252/1/924159330X.pdf [36]Srinivasa H, Baijayanti M, Raksha Y. Magnitude of drug resistant Shigellosis: a report from Bangalore. Indian J Med Microbiol. 2009 Oct-Dec;27(4):358-60. http://www.ijmm.org/article.asp?issn=0255-0857;year=2009;volume=27;issue=4;spage=358;epage=360;aulast=Srinivasa http://www.ncbi.nlm.nih.gov/pubmed/19736408?tool=bestpractice.com [37]Centers for Disease Control and Prevention (CDC) Health Alert Network (HAN). Update – CDC recommendations for managing and reporting Shigella infections with possible reduced susceptibility to ciprofloxacin. 7 June 2018 [internet publication]. https://emergency.cdc.gov/han/han00411.asp [38]Allen GP, Harris KA. In vitro resistance selection in Shigella flexneri by azithromycin, ceftriaxone, ciprofloxacin, levofloxacin, and moxifloxacin. Antimicrob Agents Chemother. 2017 Jun 27;61(7):e00086-17. http://aac.asm.org/content/61/7/e00086-17.long http://www.ncbi.nlm.nih.gov/pubmed/28483960?tool=bestpractice.com Patients with a history of travel to Asia are thus at increased risk of fluoroquinolone-resistant infection.[39]Folster JP, Pecic G, Bowen A, et al. Decreased susceptibility to ciprofloxacin among Shigella isolates in the United States, 2006 to 2009. Antimicrob Agents Chemother. 2011 Apr;55(4):1758-60. http://www.ncbi.nlm.nih.gov/pubmed/21220535?tool=bestpractice.com If susceptibility is detected, trimethoprim/sulfamethoxazole or ampicillin are alternative options.[22]Shane AL, Mody RK, Crump JA, et al. 2017 Infectious Diseases Society of America clinical practice guidelines for the diagnosis and management of infectious diarrhea. Clin Infect Dis. 2017 Nov 29;65(12):e45-80. https://academic.oup.com/cid/article/65/12/e45/4557073 http://www.ncbi.nlm.nih.gov/pubmed/29053792?tool=bestpractice.com [23]Centers for Disease Control and Prevention. Information for healthcare professionals: shigella-shigellosis. Dec 2023 [internet publication]. https://www.cdc.gov/shigella/audience-medical-professionals.html
Once infection has been confirmed, antibiotics should be promptly tailored to sensitivities to prevent resistance. If the correct antibiotic has been used initially but the patient is refractory to treatment, further cultures should be sent to exclude another pathogen, or an alternative diagnosis should be considered.
Primary options
ciprofloxacin: children: 15 mg/kg orally twice daily for 3 days, maximum 500 mg/dose; adults: 500 mg orally twice daily for 3 days
OR
ceftriaxone: children: 50-100 mg/kg intramuscularly/intravenously every 24 hours for 2-5 days, maximum 2 g/dose; adults: 1-2 g intramuscularly/intravenously every 24 hours for 2-5 days
OR
azithromycin: children: 6-20 mg/kg orally once daily for 1-5 days; adults: 1000-1500 mg orally once daily for 1-5 days
Secondary options
sulfamethoxazole/trimethoprim: children ≥2 months of age: 8-10 mg/kg/day orally given in 2 divided doses for 3-5 days, maximum 160 mg/dose; adults: 160 mg orally twice daily for 5-7 days
More sulfamethoxazole/trimethoprimDose refers to trimethoprim component.
OR
ampicillin: children: 50-100 mg/kg/day orally given in 4 divided doses for 5-7 days, maximum 2000 mg/day; adults: 500 mg orally four times daily for 5-7 days
antipyretics or analgesics
Treatment recommended for SOME patients in selected patient group
Symptomatic treatment should be given in case of fever and/or pain.
Primary options
acetaminophen: infants and children: 10-15 mg/kg orally every 4-6 hours when required, maximum 75 mg/kg/day; adults: 325-1000 mg orally every 4-6 hours when required, maximum 4000 mg/day
intravenous rehydration followed by maintenance oral rehydration solution
Hospitalization and intravenous rehydration therapy may initially be required for patients with severe dehydration or vomiting. Once rehydrated, maintenance therapy with oral rehydration solution (ORS) is recommended.[13]World Health Organization. Guidelines for the control of shigellosis, including epidemics due to Shigella dysenteriae type 1. 2005 [internet publication]. http://apps.who.int/iris/bitstream/10665/43252/1/924159330X.pdf If rehydrated patients are unable to drink, maintenance therapy with ORS may be provided nasogastrically (when intravenous hydration is no longer required and any vomiting resolves).
Oral rehydration therapy using an approved ORS is safer than use of other beverages, which may be too concentrated and contain inappropriate carbohydrate and electrolyte concentrations. Homemade preparations may be equally problematic because errors may occur.[14]King CK, Glass R, Bresee JS, et al. Managing acute gastroenteritis among children: oral rehydration, maintenance, and nutritional therapy. MMWR Recomm Rep. 2003 Nov 21;52(RR-16):1-16. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5216a1.htm http://www.ncbi.nlm.nih.gov/pubmed/14627948?tool=bestpractice.com The World Health Organization recommends low-osmolarity ORS formula for diarrhea in all age groups.[31]UNICEF/WHO. Diarrhoea: why children are still dying and what can be done. 2009 [internet publication]. https://www.who.int/publications/i/item/9789241598415
early nutritional support
Treatment recommended for SOME patients in selected patient group
Early nutritional support has been found to improve outcomes, especially in the context of malnutrition. Continued feeding promotes recovery. Frequent small meals with familiar foods, rich in energy and protein, should be provided. Breastfed infants and children should continue to be breastfed as often, and for as long, as they want.[13]World Health Organization. Guidelines for the control of shigellosis, including epidemics due to Shigella dysenteriae type 1. 2005 [internet publication]. http://apps.who.int/iris/bitstream/10665/43252/1/924159330X.pdf
The addition of green bananas to meals has been shown to reduce the duration of symptoms of shigellosis in children >6 months of age.[32]Rabbani GH, Ahmed S, Hossain I, et al. Green banana reduces clinical severity of childhood shigellosis: a double-blind, randomized, controlled clinical trial. Pediatr Infect Dis J. 2009 May;28(5):420-5.
http://www.ncbi.nlm.nih.gov/pubmed/19319017?tool=bestpractice.com
In low- and middle-income countries, a 10- to 14-day course of zinc supplementation is recommended by the World Health Organization in children <6 years of age with acute diarrhea.[13]World Health Organization. Guidelines for the control of shigellosis, including epidemics due to Shigella dysenteriae type 1. 2005 [internet publication].
http://apps.who.int/iris/bitstream/10665/43252/1/924159330X.pdf
[ ]
Is there randomized controlled trial evidence to support the use of oral zinc to treat acute diarrhea in children?/cca.html?targetUrl=https://cochranelibrary.com/cca/doi/10.1002/cca.1546/fullShow me the answer
antibiotic therapy
Treatment recommended for SOME patients in selected patient group
Antibiotic therapy is reserved for where it is clinically indicated or when public health officials advise treatment in an outbreak setting or to reduce the likelihood of transmission in certain settings or situations.[35]Centers for Disease Control and Prevention. Emergency preparedness and response: increase in extensively drug-resistant shigellosis in the United States. Feb 2023 [internet publication]. https://emergency.cdc.gov/han/2023/han00486.asp Clinical indications for empirical antibiotics include all cases of fever with bloody diarrhea, bacillary dysentery, and abdominal cramping.[22]Shane AL, Mody RK, Crump JA, et al. 2017 Infectious Diseases Society of America clinical practice guidelines for the diagnosis and management of infectious diarrhea. Clin Infect Dis. 2017 Nov 29;65(12):e45-80. https://academic.oup.com/cid/article/65/12/e45/4557073 http://www.ncbi.nlm.nih.gov/pubmed/29053792?tool=bestpractice.com Antibiotics are also recommended for infants ages <3 months with suspicion of Shigella infection and people with body temperatures ≥38.5°C and/or signs of sepsis who have recently traveled internationally.[22]Shane AL, Mody RK, Crump JA, et al. 2017 Infectious Diseases Society of America clinical practice guidelines for the diagnosis and management of infectious diarrhea. Clin Infect Dis. 2017 Nov 29;65(12):e45-80. https://academic.oup.com/cid/article/65/12/e45/4557073 http://www.ncbi.nlm.nih.gov/pubmed/29053792?tool=bestpractice.com Antibiotics may be considered in people who are immunocompromised and have severe illness and bloody diarrhea.[22]Shane AL, Mody RK, Crump JA, et al. 2017 Infectious Diseases Society of America clinical practice guidelines for the diagnosis and management of infectious diarrhea. Clin Infect Dis. 2017 Nov 29;65(12):e45-80. https://academic.oup.com/cid/article/65/12/e45/4557073 http://www.ncbi.nlm.nih.gov/pubmed/29053792?tool=bestpractice.com
First-line options are azithromycin, ciprofloxacin, or ceftriaxone.[1]Center for Disease Control and Prevention. CDC Yellow Book 2024: health information for international travel. Section 5: travel-associated infections & diseases - shigellosis. Jun 2023 [internet publication]. https://wwwnc.cdc.gov/travel/yellowbook/2024/infections-diseases/shigellosis [22]Shane AL, Mody RK, Crump JA, et al. 2017 Infectious Diseases Society of America clinical practice guidelines for the diagnosis and management of infectious diarrhea. Clin Infect Dis. 2017 Nov 29;65(12):e45-80. https://academic.oup.com/cid/article/65/12/e45/4557073 http://www.ncbi.nlm.nih.gov/pubmed/29053792?tool=bestpractice.com The choice of drug is dependent on local sensitivities. If available, antimicrobial susceptibility testing should be carried out before treating with antibiotics.[1]Center for Disease Control and Prevention. CDC Yellow Book 2024: health information for international travel. Section 5: travel-associated infections & diseases - shigellosis. Jun 2023 [internet publication]. https://wwwnc.cdc.gov/travel/yellowbook/2024/infections-diseases/shigellosis The rapid emergence of fluoroquinolone resistance is a concern, particularly in India and China.[13]World Health Organization. Guidelines for the control of shigellosis, including epidemics due to Shigella dysenteriae type 1. 2005 [internet publication]. http://apps.who.int/iris/bitstream/10665/43252/1/924159330X.pdf [36]Srinivasa H, Baijayanti M, Raksha Y. Magnitude of drug resistant Shigellosis: a report from Bangalore. Indian J Med Microbiol. 2009 Oct-Dec;27(4):358-60. http://www.ijmm.org/article.asp?issn=0255-0857;year=2009;volume=27;issue=4;spage=358;epage=360;aulast=Srinivasa http://www.ncbi.nlm.nih.gov/pubmed/19736408?tool=bestpractice.com [37]Centers for Disease Control and Prevention (CDC) Health Alert Network (HAN). Update – CDC recommendations for managing and reporting Shigella infections with possible reduced susceptibility to ciprofloxacin. 7 June 2018 [internet publication]. https://emergency.cdc.gov/han/han00411.asp [38]Allen GP, Harris KA. In vitro resistance selection in Shigella flexneri by azithromycin, ceftriaxone, ciprofloxacin, levofloxacin, and moxifloxacin. Antimicrob Agents Chemother. 2017 Jun 27;61(7):e00086-17. http://aac.asm.org/content/61/7/e00086-17.long http://www.ncbi.nlm.nih.gov/pubmed/28483960?tool=bestpractice.com Patients with a history of travel to Asia are thus at increased risk of fluoroquinolone-resistant infection.[39]Folster JP, Pecic G, Bowen A, et al. Decreased susceptibility to ciprofloxacin among Shigella isolates in the United States, 2006 to 2009. Antimicrob Agents Chemother. 2011 Apr;55(4):1758-60. http://www.ncbi.nlm.nih.gov/pubmed/21220535?tool=bestpractice.com If susceptibility is detected, trimethoprim/sulfamethoxazole or ampicillin are alternative options.[22]Shane AL, Mody RK, Crump JA, et al. 2017 Infectious Diseases Society of America clinical practice guidelines for the diagnosis and management of infectious diarrhea. Clin Infect Dis. 2017 Nov 29;65(12):e45-80. https://academic.oup.com/cid/article/65/12/e45/4557073 http://www.ncbi.nlm.nih.gov/pubmed/29053792?tool=bestpractice.com [23]Centers for Disease Control and Prevention. Information for healthcare professionals: shigella-shigellosis. Dec 2023 [internet publication]. https://www.cdc.gov/shigella/audience-medical-professionals.html
Once infection has been confirmed, antibiotics should be promptly tailored to sensitivities to prevent resistance. If the correct antibiotic has been used initially but the patient is refractory to treatment, further cultures should be sent to exclude another pathogen, or an alternative diagnosis should be considered.
Consult with a specialist for guidance on duration of treatment in severe disease.
Primary options
ciprofloxacin: children: 15 mg/kg orally/intravenously twice daily, maximum 500 mg/dose; adults: 500 mg orally twice daily, or 400 mg intravenously every 12 hours
OR
ceftriaxone: children: 50-100 mg/kg intramuscularly/intravenously every 24 hours, maximum 2 g/dose; adults: 1-2 g intramuscularly/intravenously every 24 hours
OR
azithromycin: children: 6-20 mg/kg orally once daily; adults: 1000-1500 mg orally once daily
Secondary options
sulfamethoxazole/trimethoprim: children ≥2 months of age: 8-10 mg/kg/day orally given in 2 divided doses for 3-5 days, maximum 160 mg/dose; adults: 160 mg orally twice daily for 5-7 days
More sulfamethoxazole/trimethoprimDose refers to trimethoprim component.
OR
ampicillin: children: 50-100 mg/kg/day orally given in 4 divided doses for 5-7 days, maximum 2000 mg/day; adults: 500 mg orally four times daily for 5-7 days
antipyretics or analgesics
Treatment recommended for SOME patients in selected patient group
Symptomatic treatment should be given in case of fever and/or pain.
Primary options
acetaminophen: infants and children: 10-15 mg/kg orally every 4-6 hours when required, maximum 75 mg/kg/day; adults: 325-1000 mg orally every 4-6 hours when required, maximum 4000 mg/day
Choose a patient group to see our recommendations
Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups. See disclaimer
Use of this content is subject to our disclaimer